Urethral Pain Syndrome: a Systematic Review
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
CMS Manual System Human Services (DHHS) Pub
Department of Health & CMS Manual System Human Services (DHHS) Pub. 100-07 State Operations Centers for Medicare & Provider Certification Medicaid Services (CMS) Transmittal 8 Date: JUNE 28, 2005 NOTE: Transmittal 7, of the State Operations Manual, Pub. 100-07 dated June 27, 2005, has been rescinded and replaced with Transmittal 8, dated June 28, 2005. The word “wound” was misspelled in the Interpretive Guidance section. All other material in this instruction remains the same. SUBJECT: Revision of Appendix PP – Section 483.25(d) – Urinary Incontinence, Tags F315 and F316 I. SUMMARY OF CHANGES: Current Guidance to Surveyors is entirely replaced by the attached revision. The two tags are being combined as one, which will become F315. Tag F316 will be deleted. The regulatory text for both tags will be combined, followed by this revised guidance. NEW/REVISED MATERIAL - EFFECTIVE DATE*: June 28, 2005 IMPLEMENTATION DATE: June 28, 2005 Disclaimer for manual changes only: The revision date and transmittal number apply to the red italicized material only. Any other material was previously published and remains unchanged. However, if this revision contains a table of contents, you will receive the new/revised information only, and not the entire table of contents. II. CHANGES IN MANUAL INSTRUCTIONS: (N/A if manual not updated.) (R = REVISED, N = NEW, D = DELETED) – (Only One Per Row.) R/N/D CHAPTER/SECTION/SUBSECTION/TITLE R Appendix PP/Tag F315/Guidance to Surveyors – Urinary Incontinence D Appendix PP/Tag F316/Urinary Incontinence III. FUNDING: Medicare contractors shall implement these instructions within their current operating budgets. IV. ATTACHMENTS: Business Requirements x Manual Instruction Confidential Requirements One-Time Notification Recurring Update Notification *Unless otherwise specified, the effective date is the date of service. -
Mimickers of Urothelial Carcinoma and the Approach to Differential Diagnosis
Review Mimickers of Urothelial Carcinoma and the Approach to Differential Diagnosis Claudia Manini 1, Javier C. Angulo 2,3 and José I. López 4,* 1 Department of Pathology, San Giovanni Bosco Hospital, 10154 Turin, Italy; [email protected] 2 Clinical Department, Faculty of Medical Sciences, European University of Madrid, 28907 Getafe, Spain; [email protected] 3 Department of Urology, University Hospital of Getafe, 28905 Getafe, Spain 4 Department of Pathology, Cruces University Hospital, Biocruces-Bizkaia Health Research Institute, 48903 Barakaldo, Spain * Correspondence: [email protected]; Tel.: +34-94-600-6084 Received: 17 December 2020; Accepted: 18 February 2021; Published: 25 February 2021 Abstract: A broad spectrum of lesions, including hyperplastic, metaplastic, inflammatory, infectious, and reactive, may mimic cancer all along the urinary tract. This narrative collects most of them from a clinical and pathologic perspective, offering urologists and general pathologists their most salient definitory features. Together with classical, well-known, entities such as urothelial papillomas (conventional (UP) and inverted (IUP)), nephrogenic adenoma (NA), polypoid cystitis (PC), fibroepithelial polyp (FP), prostatic-type polyp (PP), verumontanum cyst (VC), xanthogranulomatous inflammation (XI), reactive changes secondary to BCG instillations (BCGitis), schistosomiasis (SC), keratinizing desquamative squamous metaplasia (KSM), post-radiation changes (PRC), vaginal-type metaplasia (VM), endocervicosis (EC)/endometriosis (EM) (müllerianosis), -
Urinary Tract Infection (UTI): Western and Ayurvedic Diagnosis and Treatment Approaches
Urinary tract infection (UTI): Western and Ayurvedic Diagnosis and Treatment Approaches. By: Mahsa Ranjbarian Urinary system Renal or Urinary system is one of the 10 body systems that we have. This system is the body drainage system. The urinary system is composed of kidneys (vrikka), ureters (mutravaha nadis), bladder(mutrashaya) and urethra(mutramarga). The kidneys are a pair of bean-shaped, fist size organs that lie in the middle of the back, just below the rib cage, one on each side of the spine. Ureters are tubes that carry the wastes or urine from the kidneys to the bladder. The urine finally exit the body from the urethra when the bladder is full.1 Urethras length is shorter in women than men due to the anatomical differences. Major function of the urinary system is to remove wastes and water from our body through urination. Other important functions of the urinary system are as follows. 1. Prevent dehydration and at the same time prevent the buildup of extra fluid in the body 2. Cleans the blood of metabolic wastes 3. Removing toxins from the body 4. Maintaining the homeostasis of many factors including blood PH and blood pressure 5. Producing erythrocytes 6. make hormones that help regulate blood pressure 7. keep bones strong 8. keep levels of electrolytes, such as potassium and phosphate, stable 2 The Urinary system like any other systems of our body is working under the forces of three doshas, subdoshas. Mutravaha srotas, Ambuvahasrota and raktavahasrota are involved in formation and elimination of the urine. Urine gets separated from the rasa by maladhara kala with the help of pachaka pitta and samana vayu and then through the mutravaha srota(channels carrying the urine) it is taken to the bladder. -
Surgical Treatment of Urinary Incontinence in Men
Committee 13 Surgical Treatment of Urinary Incontinence in Men Chairman S. HERSCHORN (Canada) Members H. BRUSCHINI (Brazil), C.COMITER (USA), P.G RISE (France), T. HANUS (Czech Republic), R. KIRSCHNER-HERMANNS (Germany) 1121 CONTENTS I. INTRODUCTION VIII. TRAUMATIC INJURIES OF THE URETHRA AND PELVIC FLOOR II. EVALUATION PRIOR TO SURGICAL THERAPY IX. CONTINUING PEDIATRIC III. INCONTINENCE AFTER RADICAL PROBLEMS INTO ADULTHOOD: THE PROSTATECTOMY FOR PROSTATE EXSTROPHY-EPISPADIAS COMPLEX CANCER X. DETRUSOR OVERACTIVITY AND IV. INCONTINENCE AFTER REDUCED BLADDER CAPACITY PROSTATECTOMY FOR BENIGN DISEASE XI. URETHROCUTANEOUS AND V. SURGERY FOR INCONTINENCE IN RECTOURETHRAL FISTULAE ELDERLY MEN VI. INCONTINENCE AFTER XII. THE ARTIFICIAL URINARY EXTERNAL BEAM RADIOTHERAPY SPHINCTER (AUS) ALONE AND IN COMBINATION WITH SURGERY FOR PROSTATE CANCER XIII. SUMMARY AND RECOMMENDATIONS VII. INCONTINENCE AFTER OTHER TREATMENT FOR PROSTATE CANCER REFERENCES 1122 Surgical Treatment of Urinary Incontinence in Men S. HERSCHORN, H. BRUSCHINI, C. COMITER, P. GRISE, T. HANUS, R. KIRSCHNER-HERMANNS high-intensity focused ultrasound, other pelvic I. INTRODUCTION operations and trauma is a particularly challenging problem because of tissue damage outside the lower Surgery for male incontinence is an important aspect urinary tract. The artificial sphincter implant is the of treatment with the changing demographics of society most widely used surgical procedure but complications and the continuing large numbers of men undergoing may be more likely than in other areas and other surgery and other treatments for prostate cancer. surgical approaches may be necessary. Unresolved problems from pediatric age and patients with Basic evaluation of the patient is similar to other areas refractory incontinence from overactive bladders may of incontinence and includes primarily a clinical demand a variety of complex reconstructive surgical approach with history, frequency-volume chart or procedures. -
A New Look at the Etiology of Interstitial Cystitis/Bladder Pain Syndrome: Extraordinary Cultivations
International Urology and Nephrology (2019) 51:1961–1967 https://doi.org/10.1007/s11255-019-02248-5 UROLOGY - ORIGINAL PAPER A new look at the etiology of interstitial cystitis/bladder pain syndrome: extraordinary cultivations Tahsin Batuhan Aydogan1 · Oznur Gurpinar2 · Ozgen Koseoglu Eser2 · Begum Aydogan Mathyk3 · Ali Ergen1 Received: 25 April 2019 / Accepted: 24 July 2019 / Published online: 30 July 2019 © Springer Nature B.V. 2019 Abstract Purpose So far, studies have not clearly identifed infectious agents as an etiological factor for interstitial cystitis (IC). Spe- cifc microbiological diagnosis for detecting the pathogen with higher sensitivity in IC may decrease the treatment costs and increase psychosocial health of the patients. Methods A prospective clinical study was performed in 26 IC patients and 20 controls between April and September 2017. All participants were asked to give mid-stream urine sample for routine urine cultures. Followed by the negative results, symptomatic 26 patients were evaluated for L-form pathogen existence by extraordinary cultivation methods. Biopsy sam- ples were taken from 19 patients with ulcerative lesions in the bladder while collecting sterile urine samples from all 26 patients. PG broth, 5% sheep blood agar, EMB, Sabouraud’s dextrose, LEM, and GYPA were used. Followed by the 1st day inoculations, all inoculated PG broths were subcultured into the same solid media at the 2nd and 10th days in case of any growth after incubation of 24 h under 35–37 °C. The “O’Leary Sant Symptom and Problem Index” score forms were used to evaluate response to the appropriate treatment for those patients with documented pathogens. -
Interstitial Cystitis/Painful Bladder Syndrome
What I need to know about Interstitial Cystitis/Painful Bladder Syndrome U.S. Department of Health and Human Services National Kidney and Urologic Diseases NATIONAL INSTITUTES OF HEALTH Information Clearinghouse What I need to know about Interstitial Cystitis/Painful Bladder Syndrome U.S. Department of Health and Human Services National Kidney and Urologic Diseases NATIONAL INSTITUTES OF HEALTH Information Clearinghouse Contents What is interstitial cystitis/painful bladder syndrome (IC/PBS)? ............................................... 1 What are the signs of a bladder problem? ............ 2 What causes bladder problems? ............................ 3 Who gets IC/PBS? ................................................... 4 What tests will my doctor use for diagnosis of IC/PBS? ............................................................... 5 What treatments can help IC/PBS? ....................... 7 Points to Remember ............................................. 14 Hope through Research........................................ 15 Pronunciation Guide ............................................. 16 For More Information .......................................... 17 Acknowledgments ................................................. 18 What is interstitial cystitis/painful bladder syndrome (IC/PBS)? Interstitial cystitis*/painful bladder syndrome (IC/PBS) is one of several conditions that causes bladder pain and a need to urinate frequently and urgently. Some doctors have started using the term bladder pain syndrome (BPS) to describe this condition. Your bladder is a balloon-shaped organ where your body holds urine. When you have a bladder problem, you may notice certain signs or symptoms. *See page 16 for tips on how to say the words in bold type. 1 What are the signs of a bladder problem? Signs of bladder problems include ● Urgency. The feeling that you need to go right now! Urgency is normal if you haven’t been near a bathroom for a few hours or if you have been drinking a lot of fluids. -
Managing Female Urethral Diverticulum with a Standardized Technique Using a Pacifier-Trick Artifice to Facilitate Dissection
International Urogynecology Journal (2019) 30:789–794 https://doi.org/10.1007/s00192-018-3754-8 ORIGINAL ARTICLE Managing female urethral diverticulum with a standardized technique using a pacifier-trick artifice to facilitate dissection Philippe Neveü1 & Idir Ouzaid1 & Evanguelos Xylinas1 & Christophe Egrot1 & Vincent Ravery1 & Jean-François Hermieu1 Received: 21 February 2018 /Accepted: 12 August 2018 /Published online: 3 September 2018 # The International Urogynecological Association 2018 Abstract Introduction and hypothesis Managing urethral diverticula is challenging because of recurrence rate and postoperative compli- cations. Herein, we report a standardized, single-institution experience of surgical treatment of urethral diverticula in women. Methods The medical record of 37 female patients treated for urethral diverticula between 2005 and 2017 in a single institution were reviewed. All patients were operated in a standardized genupectoral position using a technical artifice called the pacifier trick to inflate diverticula throughout the procedure and facilitate its dissection. Symptoms at diagnosis, imaging findings, surgical parameters, postoperative complications, and recurrence rates were collected and are presented. Results Median age was 39 ± 11 (range 21–67) years. At diagnosis, recurrent urinary tract infections (UTI) (67%), vaginal mass (46%), pelvic pain (43%), dyspareunia (27%), and urinary incontinence (UI) (24%) were the most commonly reported symp- toms. Median operative time was 98 ± 31 (range 40–150) min. After a mean follow-up of 1 year, recurrence occurred in one (3%) patient. Immediate de novo postoperative UI decreased from 27% immediately after surgery to 3% after pelvic physical therapy. Pathological analyses found no malignant histology. Conclusions Surgical management of urethral diverticula in women is technically demanding. -
Symptoms of Overactive Bladder and Interstitial Cystitis – How Different?
183 Homma Y1, Tanaka M1, Niimi A1 1. Japan Red Cross Medical Centre SYMPTOMS OF OVERACTIVE BLADDER AND INTERSTITIAL CYSTITIS – HOW DIFFERENT? Hypothesis / aims of study Overactive bladder (OAB) is a symptom syndrome of urgency, frequency or urgency incontinence [1]. Interstitial cystitis (IC) is a bladder disease with a symptom syndrome of urgency, frequency, or bladder pain. Difference in symptoms of these confusable disorders is to be examined. Study design, materials and methods Female patients with OAB or IC and asymptomatic controls were recruited for the study. Diagnosis of OAB is based on 1) OAB symptom score [2] larger than 5 and/or urgency incontinence, and 2) exclusion of stress urinary incontinence and other obvious diseases. IC was diagnosed by 1) O’Leary & Sant’s symptom score [3] larger than 7 and/or bladder pain, 2) exclusion of other obvious diseases, and 3) Hunner’s ulcer or bladder bleeding at hydrodistension under anesthesia. The subjects recorded, in 3-day bladder diary, time voided, voided volume and intensity (0: none, 1: slightly, 2: moderately, 3: a lot) of 6 sensations or symptoms (urge to void, fear of leakage, amount of leakage, bladder discomfort, bladder pain and feeling of incomplete emptying) for each micturition. Additionally the urge questionnaire of 5 questions addressing the conditions during the last week was administered: 1) Did you feel urge to void that was not followed by voiding? (Response: yes, no), 2) Did you feel strong urge to void? (yes, no), 3) In case of yes in question 2, did you feel strong urge to void suddenly? (yes, no), 4) What happened or might happen, if you held strong urge to void for a long time, 1 hour for example ? (Response: leak urine, feel discomfort and/or pain, both), 5) In case of discomfort and/or pain in question 4, could you tell these 2 sensations apart? (yes, no). -
Interstitial Cystitis? You May Have Interstitial Cystitis If Any of the Following Occur: Interstitial Cystitis • You Have to Urinate Often Or Urgently
the bladder wall. An autoimmune response (when antibodies are made that act against a part of the body such as in rheumatoid arthritis) may also be the cause in some people. How does my doctor know I have interstitial cystitis? You may have interstitial cystitis if any of the following occur: Interstitial Cystitis • You have to urinate often or urgently. • You have persistent pelvic or bladder pain. A Guide for Women • A doctor finds bladder wall inflammation, pinpoint bleed- 1. What is interstitial cystitis? ing or ulcers during an exam with a special telescope 2. What causes interstitial cystitis? (called a cystoscope) used to look inside your bladder. 3. How does my doctor know I have interstitial cystitis? • Your doctor has ruled out other diseases such as urinary 4. How is interstitial cystitis treated? tract infections, vaginal infections, bladder cancer, and sexually transmitted diseases that may mimic some of the 5. Other Treatment Options symptoms of interstitial cystitis. 6. Where can I get more information about interstitial How is interstitial cystitis treated? cystitis? Because the causes of IC are unknown, current treatments are aimed at relieving symptoms. One or a combination of treat- ments helps most people for variable periods. As researchers What is interstitial cystitis? learn more about IC the list of potential treatments will change, Interstitial cystitis (IC) is a term used to describe the condition so patients should discuss their options with a doctor. Most peo- of bladder pain or discomfort with a frequent and often urgent ple feel better after trying one or more of the following treat- need to pass urine. -
Guide to Treating Your Child's Daytime Or Nighttime Accidents
A GUIDE TO TREATING YOUR CHILD’S Daytime or Nighttime Accidents, Urinary Tract Infections and Constipation UCSF BENIOFF CHILDREN’S HOSPITALS UROLOGY DEPARTMENT This booklet contains information that will help you understand more about your child’s bladder problem(s) and provides tips you can use at home before your first visit to the urology clinic. www.childrenshospitaloakland.org | www.ucsfbenioffchildrens.org 2 | UCSF BENIOFF CHILDREN’S HOSPITALS UROLOGY DEPARTMENT Table of Contents Dear Parent(s), Your child has been referred to the Pediatric Urology Parent Program at UCSF Benioff Children’s Hospitals. We specialize in the treatment of children with bladder and bowel dysfunction. This booklet contains information that will help you understand more about your child’s problem(s) and tips you can use at home before your first visit to the urology clinic. Please review the sections below that match your child’s symptoms. 1. Stool Retention and Urologic Problems (p.3) (Bowel Dysfunction) 2. Bladder Dysfunction (p.7) Includes daytime incontinence (wetting), urinary frequency and infrequency, dysuria (painful urination) and overactive bladder 3. Urinary Tract Infection and Vesicoureteral Reflux (p. 10) 4. Nocturnal Enuresis (p.12) Introduction (Nighttime Bedwetting) It’s distressing to see your child continually having accidents. The good news is that the problem is very 5. Urologic Tests (p.15) common – even if it doesn’t feel that way – and that children generally outgrow it. However, the various interventions we offer can help resolve the issue sooner THIS BOOKLET ALSO CONTAINS: rather than later. » Resources for Parents (p.16) » References (p.17) Childhood bladder and bowel dysfunction takes several forms. -
(Part 1): Management of Male Urethral Stricture Disease
EURURO-9412; No. of Pages 11 E U R O P E A N U R O L O G Y X X X ( 2 0 2 1 ) X X X – X X X ava ilable at www.sciencedirect.com journa l homepage: www.europeanurology.com Review – Reconstructive Urology European Association of Urology Guidelines on Urethral Stricture Disease (Part 1): Management of Male Urethral Stricture Disease a, b c d Nicolaas Lumen *, Felix Campos-Juanatey , Tamsin Greenwell , Francisco E. Martins , e f a c g Nadir I. Osman , Silke Riechardt , Marjan Waterloos , Rachel Barratt , Garson Chan , h i a j Francesco Esperto , Achilles Ploumidis , Wesley Verla , Konstantinos Dimitropoulos a b Division of Urology, Gent University Hospital, Gent, Belgium; Urology Department, Marques de Valdecilla University Hospital, Santander, Spain; c d Department of Urology, University College London Hospital, London, UK; Department of Urology, Santa Maria University Hospital, University of Lisbon, e f Lisbon, Portugal; Department of Urology, Sheffield Teaching Hospitals, Sheffield, UK; Department of Urology, University Medical Center Hamburg- g h Eppendorf, Hamburg, Germany; Division of Urology, University of Saskatchewan, Saskatoon, Canada; Department of Urology, Campus Biomedico i j University of Rome, Rome, Italy; Department of Urology, Athens Medical Centre, Athens, Greece; Aberdeen Royal Infirmary, Aberdeen, UK Article info Abstract Article history: Objective: To present a summary of the 2021 version of the European Association of Urology (EAU) guidelines on management of male urethral stricture disease. Accepted May 15, 2021 Evidence acquisition: The panel performed a literature review on these topics covering a time frame between 2008 and 2018, and used predefined inclusion and exclusion criteria Associate Editor: for the literature to be selected. -
UIJ Urotoday International Journal® the Short-Term Outcome of Urethral Stricture Disease Management in HIV and Non-HIV Infected Patients: a Comparative Study
UIJ UroToday International Journal® The Short-Term Outcome of Urethral Stricture Disease Management in HIV and Non-HIV Infected Patients: A Comparative Study Mohamed Awny Labib, Michael Silumbe, Kasonde Bowa Submitted April 30, 2012 - Accepted for Publication December 27, 2012 ABSTRACT Purpose: This study intends to compare short-term outcomes of treatment of urethral stricture disease between human immunodeficiency virus (HIV) seropositive and HIV seronegative patients at the University Teaching Hospital (UTH) in Lusaka. Methods: This was a prospective cohort study conducted on patients presenting with urethral stricture disease at the UTH, Lusaka, Zambia, between October 2009 and December 2010. One arm included HIV seropositive patients and the other arm had HIV seronegative patients. The recruited patients underwent urethral dilatation, anastomotic urethroplasty, and staged urethroplasty. They were followed-up postoperatively for 6 months, and recurrence and complication rates were compared between the 2 groups. Other parameters studied included patient demographics, cluster of differentiation (CD4) cell counts in positive patients, HIV World Health Organization (WHO) stages, stricture etiology, stricture sites, and stricture lengths. The collected data was analyzed using SPSS 16. Results: A total of 71 patients with a mean age of 38.04 years who had urethral stricture disease were recruited for this study. Of the patients, 37% (26) were HIV seropositive while 63% (45) were seronegative, and 53.8% (14) of the seropositive patients were on highly active antiretroviral therapy (HAART). Of the urethral strictures, 45% (32) resulted from urethritis, and the prevalence of HIV in patients presenting with post-urethritis stricture disease was 50% (16/32). Of the strictures, 73.2% (N = 52) were located in the bulbar urethra, 19.7% (N = 14) were in the penile urethra, and 5.6% (N = 4) were located in the membranous urethra.